|
fhB7H3.CAR-Ts Clinical Trials
1 actively recruiting trial
▼ -1 trial since August 2026
Also known as: B7H3 targeting chimeric antigen receptor T cells
Pipeline
Phase 1/2: 1
Top Sponsors
- The Affiliated Hospital of Xuzhou Medical University1
Indications
- Liver Disease1
- Liver Cancer1
- Hepatocellular Carcinoma1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.